The word "Arformoterol" in example sentences
Goodman believes that investors will increasingly return to Sepracor as its Lunesta sleep-aid continues its ramp in the face of new product launches, Xopenex franchise continues to grow, and arformoterol is approved by year-end 2006 or early 2007. Sepracor Shareholders Can Rest Easy After 'Excellent' Q4
"We still believe that Sepracor is a good new product story with two products (Lunesta and Xopenex MDI) early in their life cycles and another product (arformoterol) expected to launch in 2007," the analyst added. Sepracor Shares Seen As Undervalued
Approval for respiratory drug arformoterol could spark additional gains, the analyst added. Sepracor Gains Reflect Pfizer Buyout Speculation
According to investigators, Medicare paid for 7 million units of the drug arformoterol, even though the manufacturer and the three largest wholesalers sold only 750,000 units in the area in 2008 and the first half of 2009. StarTribune.com rss feed
The spike in arformoterol only came after authorities tried to crack down on another inhaler drug, and illustrates a constant problem plaguing investigators. StarTribune.com rss feed
Fraudulent providers quickly realized they couldn't get as much money for that drug and began billing Medicare for arformoterol at rates exceeding the amount of drugs available. StarTribune.com rss feed
In fact, the high-dose arformoterol group showed somewhat greater reductions in rescue and supplemental medication use at six months than during the first few weeks of treatment. MedPageToday.com - medical news plus CME for physicians
Steven Brown, M.D., a pulmonologist in Glendale, Wis., called the findings reassuring, especially in light of the black-box warning on arformoterol and all other products containing long-acting beta agonists. MedPageToday.com - medical news plus CME for physicians
The values for arformoterol after six months were 0.24 L for the higher dose and 0.20 L for the lower dose, slightly lower than at the trial's start. MedPageToday.com - medical news plus CME for physicians
Explain to interested patients that the study identified no major safety concerns with arformoterol (Brovana) either at the currently approved dose or at a higher dose. MedPageToday.com - medical news plus CME for physicians
Other analyses of adverse events showed no differences between arformoterol and formoterol, or between the two arformoterol doses. MedPageToday.com - medical news plus CME for physicians
Declines in use of rescue and supplemental medications were also largely maintained, more so with the two arformoterol groups than with formoterol. MedPageToday.com - medical news plus CME for physicians
PHILADELPHIA, Oct. 30 -- No safety concerns and no loss of efficacy were seen in a six-month study of nebulized arformoterol (Brovana), a long-acting beta agonist for chronic obstructive pulmonary disease. MedPageToday.com - medical news plus CME for physicians
BROVANA® brand arformoterol tartrate Inhalation Solution, OMNARIS ™ brand ciclesonide Nasal Spray and Medlogs - Recent stories
Dr. Hanania said the study was prompted by concerns about the safety of long-acting beta agonists including arformoterol, particularly in nebulized formulations. MedPageToday.com - medical news plus CME for physicians
